Molecular aspects of monoamine oxidase B
RR Ramsay - Progress in neuro-psychopharmacology and biological …, 2016 - Elsevier
Monoamine oxidases (MAO) influence the monoamine levels in brain by virtue of their role
in neurotransmitter breakdown. MAO B is the predominant form in glial cells and in platelets …
in neurotransmitter breakdown. MAO B is the predominant form in glial cells and in platelets …
Procognitive Properties of Drugs with Single and Multitargeting H3 Receptor Antagonist Activities
K Nikolic, S Filipic, D Agbaba… - CNS neuroscience & …, 2014 - Wiley Online Library
The histamine H3 receptor (H3R) is an important modulator of numerous central control
mechanisms. Novel lead optimizations for H3R antagonists/inverse agonists involved …
mechanisms. Novel lead optimizations for H3R antagonists/inverse agonists involved …
[PDF][PDF] Synthesis of azolines and imidazoles and their use in drug design
A Reyes-Arellano, O Gómez-García… - Med Chem (Los …, 2016 - academia.edu
Heterocycles are very important functional groups, especially in medicinal chemistry. They
are not only pivotal in the synthesis of drugs, but also form part of the structure of a diversity …
are not only pivotal in the synthesis of drugs, but also form part of the structure of a diversity …
Analysis of the nischarin expression across human tumor types reveals its context-dependent role and a potential as a target for drug repurposing in oncology
M Ostojić, A Đurić, K Živić, J Grahovac - Plos one, 2024 - journals.plos.org
Nischarin was reported to be a tumor suppressor that plays a critical role in breast cancer
initiation and progression, and a positive prognostic marker in breast, ovarian and lung …
initiation and progression, and a positive prognostic marker in breast, ovarian and lung …
The Use of the Selective Imidazoline I1 Receptor Agonist Carbophenyline as a Strategy for Neuropathic Pain Relief: Preclinical Evaluation in a Mouse Model of …
L Micheli, L Di Cesare Mannelli, F Del Bello… - …, 2020 - Springer
Anti-cancer therapy based on the repeated administration of oxaliplatin is limited by the
development of a disabling neuropathic syndrome with detrimental effects on the patient's …
development of a disabling neuropathic syndrome with detrimental effects on the patient's …
Synthesis and Biological Evaluation of 2-Aryliminopyrrolidines as Selective Ligands for I1 Imidazoline Receptors: Discovery of New Sympatho-Inhibitory Hypotensive …
V Gasparik, H Greney, S Schann… - Journal of Medicinal …, 2015 - ACS Publications
New 2-aryliminopyrrolidines (1–18) were synthesized and tested for their binding properties
on I1 imidazoline receptors vs α2-adrenergic receptors and their blood pressure effects after …
on I1 imidazoline receptors vs α2-adrenergic receptors and their blood pressure effects after …
DABCO-catalyzed [3+ 2] annulation of sulfamate-derived cyclic imines with isocyanoacetates: synthesis of sulfamate-fused 2-imidazoline
DABCO-catalyzed [3 + 2] annulation of sulfamate-derived cyclic imines with isocyanoacetates:
synthesis of sulfamate-fused 2-imidazoline - Organic & Biomolecular Chemistry (RSC …
synthesis of sulfamate-fused 2-imidazoline - Organic & Biomolecular Chemistry (RSC …
Antagonism/Agonism Modulation to Build Novel Antihypertensives Selectively Triggering I1-Imidazoline Receptor Activation
Pharmacological studies have suggested that I1-imidazoline receptors are involved in the
regulation of cardiovascular function and that selective I1-agonists, devoid of the side effects …
regulation of cardiovascular function and that selective I1-agonists, devoid of the side effects …
Gender difference in epileptogenic effects of 2-BFI and BU224 in mice
Imidazoline I 2 receptors are involved in pain modulation and psychiatric disorders and its
ligands may represent a new therapeutic strategy against pain and depression. In particular …
ligands may represent a new therapeutic strategy against pain and depression. In particular …
Quantitative structure-activity relationship (Qsar) studies for the inhibition of maos
M Ramesh, A Muthuraman - Combinatorial Chemistry & High …, 2020 - ingentaconnect.com
Monoamine oxidases are the crucial drug targets for the treatment of neurodegenerative
disorders like depression, Parkinson's disease, and Alzheimer's disease. The enzymes …
disorders like depression, Parkinson's disease, and Alzheimer's disease. The enzymes …